Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy
- 1 May 2009
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 136 (5), 1618-1628.e2
- https://doi.org/10.1053/j.gastro.2009.01.039
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose PeginterferonNew England Journal of Medicine, 2008
- 3 COLCHICINE VERSUS PEG-INTERFERON ALFA 2B LONG TERM THERAPY: RESULTS OF THE 4 YEAR COPILOT TRIALJournal of Hepatology, 2008
- Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced FibrosisAnnals of Internal Medicine, 2007
- Sustained virological response to interferon-α is associated with improved outcome in HCV-related cirrhosis: A retrospective studyHepatology, 2007
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 2001
- Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon TherapyAnnals of Internal Medicine, 2000
- Is an “à la carte” combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?Hepatology, 2000
- Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic viewGastroenterology, 1999
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996